Low Dose Ketamine-midazolam Regimen as an Adjuvant Therapy for Painful Vaso-occlusive Crisis Refractory to Opioids in a Patient with Sickle Cell Disease：A Case Report | Zendy

AI Assistant Blog Pricing

Low Dose Ketamine-midazolam Regimen as an Adjuvant Therapy for Painful Vaso-occlusive Crisis Refractory to Opioids in a Patient with Sickle Cell Disease：A Case Report

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.